ArticlePharmaceutics2023

Does Cytokine-Release Syndrome Induced by CAR T-Cell Treatment Have an Impact on the Pharmacokinetics of Meropenem and Piperacillin/Tazobactam in Patients with Hematological Malignancies? Findings from an Observational Case-Control Study.

Chun Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.